قرار
إداري رقم (62)
لسنة 2020
باعتماد
أثمان
التحاليل
المخبرية في
مختبرات هيئة
الصحة في دبي
ــــــــــــــــــــــــــــــــــــــــــــــــــــــ
المدير
العام
بعد
الاطلاع على القانون
رقم (14) لسنة 2009
بشأن تسعير
الخدمات الحكومية
في إمارة دبي
وتعديلاته،
وعلى
القانون رقم (1)
لسنة 2016 بشأن
النظام
المالي لحكومة
دبي،
وعلى
القانون رقم (6)
لسنة 2018 بشأن
هيئة الصحة في
دبي، ويُشار
إليها فيما
بعد
بـِ"الهيئة"
وعلى
المرسوم رقم (9)
لسنة 2012
باعتماد آلية
تسعير خدمات
هيئة الصحة في
دبي،
وعلى
المرسوم رقم (17)
لسنة 2018 بشأن
إنشاء
المؤسسات
التابعة
لهيئة الصحة
في دبي وتحديد
اختصاصاتها،
وعلى
المرسوم رقم (18)
لسنة 2018 بتعيين
مُدير عام
هيئة الصحة في
دبي،
وعلى قرار المجلس
التنفيذي رقم
(18) لسنة 2018
باعتماد
الهيكل
التنظيمي
لهيئة الصحة
في دبي،
وعلى
القرار
الإداري رقم (148)
لسنة 2014 بشأن
رسوم الخدمات
الصحية،
وعلى
اعتماد دائرة
المالية
لأسعار
فحوصات مخبرية
جديدة المؤرخ
في 28/06/2020-مرجع: DOF/OUT/2020/0001504،
قررنا ما
يلي:
اعتماد
الأثمان
المادة
(1)
تُعتمد
بموجب هذا
القرار،
أثمان
التحاليل المخبرية
في مختبرات
هيئة الصحة في
دبي، وفقاً
لما هو مبيّن
في الجدول
المُلحق بهذا
القرار.
التكليف
بالتنفيذ
المادة (2)
على كافة
الوحدات
التنظيمية في
الهيئة، اتخاذ
الإجراءات
اللازمة لوضع
هذا القرار
موضع التنفيذ،
كل في مجال
اختصاصه.
الإلغاءات
المادة
(3)
يُلغى أي
نص في أي قرار
إداري آخر إلى
المدى الذي
يتعارض فيه
وأحكام هذا
القرار.
السريان
والنشر
المادة
(4)
يُعمل
بهذا القرار
من تاريخ صدوره، ويُنشر
في الجريدة
الرسمية.
حميد
القطامي
المدير
العام
صدر
في دبي بتاريخ
6 يوليو 2020 م
المـــــــــــــــــوافق
15 ذو القعدة 1441 هـ
جدول
بتحديد أثمان
التحاليل
المخبرية في
مختبرات هيئة
الصحة في دبي
S.NO: |
Service Code |
Service Description |
Proposed Price |
1 |
81214 |
BRCA1 (breast cancer 1) (eg, hereditary
breast and ovarian cancer) gene analysis; full sequence analysis and common
duplication/deletion variants (ie, exon 13 del 3.835kb, exon 13 dup 6kb, exon
14-20 del 26kb, exon 22 del 510bp, exon 8-9 del 7.1kb) |
6490 |
2 |
81408 |
Molecular pathology procedure, Level
9 (eg, analysis of > 50 exons in a single gene by DNA sequence analysis)
FBN1 (fibrillin 1) (eg, Marfan syndrome), full gene sequence NF1
(neurofibromin 1) (eg, neurofibromatosis, type 1), full gene sequence RYR1
(ryanodine receptor 1, skeletal) (eg, malignant hyperthermia), full gene
sequence VWF (von Willebrand factor) (eg, von Willebrand disease types 1 and
3), full gene sequence |
6511 |
3 |
81407 |
Molecular pathology procedure, Level
8 (eg, analysis of 26-50 exons by DNA sequence analysis, mutation scanning or
duplication/deletion variants of > 50 exons, sequence analysis of multiple
genes on 1 platform) SCN1A (sodium channel, voltage-gated, type 1, alpha
subunit) (eg, generalized epilepsy with febrile seizures), full gene sequence |
8545 |
4 |
2008127 |
ANTI SACCHAROMYCES CEREVI. ABS |
174 |
5 |
2090018 |
Aicardi-Goutières syndrome (NGS) |
6830 |
6 |
2090019 |
Aldosterone-Sensitive Distal Nephron
(NGS) |
6830 |
7 |
2090020 |
Alport syndrome (NGS) |
6830 |
8 |
2090021 |
Amyotrophic lateral sclerosis (ALS)
(NGS) |
10430 |
9 |
2090022 |
Angelman -like syndrome (NGS) |
8630 |
10 |
2090023 |
Aortopathy (NGS) |
10430 |
11 |
2090024 |
Cardiomyopathy
(ARVD/ARVC)/Arrhythmogenic right ventricular dysplasia (NGS) |
8630 |
12 |
2090025 |
Ataxia (NGS) |
10430 |
13 |
2090026 |
Ataxic polyneuropathies (NGS) |
10430 |
14 |
2090027 |
Auditory neuropathy (NGS) |
6830 |
15 |
2090028 |
Burkitt lymphoma (NGS) |
6830 |
16 |
2090029 |
C3-Glomerulopathies (C3G) (NGS) |
8630 |
17 |
2090030 |
Cardiofaciocutaneous syndrome (NGS) |
8630 |
18 |
2090031 |
Cardiomyopathy, dilated (NGS) |
10430 |
19 |
2090032 |
CFHR5-Nephropathy (NGS) |
8630 |
20 |
2090033 |
Chondrodysplasia punctate (NGS) |
6830 |
21 |
2090034 |
Congenital disorders of
glycosylation (CDG) (NGS) |
10430 |
22 |
2090035 |
Congenital heart defects (NGS) |
10430 |
23 |
2090036 |
Corneal dystrophies (NGS) |
8630 |
24 |
2090038 |
Craniosynostosis syndromes (NGS) |
10430 |
25 |
2090039 |
Cutaneous T-cell lymphoma (NGS) |
6830 |
26 |
2090040 |
Cystinuria (NGS) |
6830 |
27 |
2090041 |
Dent syndrome (NGS) |
6830 |
28 |
2090042 |
Diabetes insipidus (NGS) |
6830 |
29 |
2090043 |
Diabetes mellitus,monogenic (NGS) |
10430 |
30 |
2090044 |
Diffuse large B-cell lymphoma (NGS) |
8630 |
31 |
2090045 |
Disorders of sex development (DSD
(NGS) |
10430 |
32 |
2090046 |
Dyskeratosis congenita (NGS) |
8630 |
33 |
2090047 |
Dystonie (NGS) |
10430 |
34 |
2090048 |
Ectodermal dysplasia (NGS) |
10430 |
35 |
2090049 |
Ellis-van-Crefeld syndrome (NGS) |
7280 |
36 |
2090050 |
Epidermolysis bullosa (NGS) |
8630 |
37 |
2090051 |
Epilepsy (NGS) |
10430 |
38 |
2090052 |
Epilepsy, metabolic (NGS) |
10430 |
39 |
2090053 |
Fanconi anemia (NGS) |
8630 |
40 |
2090054 |
Fatty acid oxidation disorders (NGS) |
8630 |
41 |
2090055 |
Follicular lymphoma (NGS) |
6830 |
42 |
2090056 |
Frontotemporal dementia (NGS) |
8630 |
43 |
2090057 |
Glucocorticoid Deficiency (NGS) |
6830 |
44 |
2090058 |
Familial Gluconeogenesis (NGS) |
6830 |
45 |
2090059 |
Glycogen Storage Disease (NGS) |
7223 |
46 |
2090060 |
Growth Hormone Deficiency (NGS) |
10430 |
47 |
2090062 |
Hereditary sensory and autonomic
neuropathy (HSAN) (NGS) |
8630 |
48 |
2090063 |
Hermansky-Pudlak syndrome (NGS) |
6830 |
49 |
2090064 |
Holoprosencephaly Hyperekplexia
(NGS) |
6830 |
50 |
2090065 |
Hyperoxaluria Hypertriglyceridemia
(NGS) |
6830 |
51 |
2090066 |
Familial Hypoglycemia (NGS) |
10430 |
52 |
2090067 |
Hypogonadotropic hypogonadism (NGS) |
8630 |
53 |
2090068 |
Hypophosphatemic rickets/Phosphate
diabetes (NGS) |
8630 |
54 |
2090069 |
Ichthyosis and related disorders of
cornification (NGS) |
10430 |
55 |
2090070 |
Cholestasis, progressive familial
intrahepatic (NGS) |
6830 |
56 |
2090071 |
Kartagener syndrome (NGS) |
10430 |
57 |
2090072 |
Ketogenesis disorder (NGS) |
6830 |
58 |
2090073 |
Ketolysis disorder (NGS) |
6830 |
59 |
2090074 |
Left ventricular noncompaction (NGS) |
6830 |
60 |
2090075 |
Leigh syndrome (NGS) |
10430 |
61 |
2090076 |
Acute Myeloid Leukemia (NGS) |
8630 |
62 |
2090077 |
Atypical Chronic Myeloid Leukemia
(NGS) |
6830 |
63 |
2090078 |
Chronic Myelomonocytic Leukemia
(NGS) |
6830 |
64 |
2090079 |
Chronic Neuthrophilic Leukemia (NGS) |
6830 |
65 |
2090080 |
Leukodystrophy (NGS) |
10430 |
66 |
2090081 |
T-cell acute lymphoblastic Leukemia
(NGS) |
8630 |
67 |
2090082 |
Limb-girdle muscular dystrophy
(LGMD) (NGS) |
10430 |
68 |
2090083 |
Lissencephaly (NGS) |
10430 |
69 |
2090084 |
Loeys-Dietz syndrome (NGS) |
6830 |
70 |
2090085 |
Lysosomal disorders (NGS) |
10430 |
71 |
2090086 |
Macrocephaly (NGS) |
10430 |
72 |
2090087 |
Malignant Hyperthermia (NGS) |
6830 |
73 |
2090088 |
Mantle Cell Lymphoma (NGS) |
6830 |
74 |
2090089 |
Medullary Cystic Kidney Disease
(MCKD) (NGS) |
6830 |
75 |
2090090 |
Micromelic Dysplasia (NGS) |
10430 |
76 |
2090091 |
Metaphyseal dysplasia (NGS) |
6830 |
77 |
2090092 |
Mitochondrial encephalopathy (NGS) |
10430 |
78 |
2090093 |
Morbus Waldenström (NGS) |
6830 |
79 |
2090094 |
mtDNA Depletion/Integrity panel
(NGS) |
6830 |
80 |
2090095 |
Mucopolysaccharidosis (NGS) |
8630 |
81 |
2090096 |
Multiple Epiphyseal Dysplasia and
Pseudoachondroplasia (NGS) |
6830 |
82 |
2090097 |
Multiple Myeloma (NGS) |
6830 |
83 |
2090098 |
Muscular Dystrophies,Congenital
(NGS) |
10430 |
84 |
2090099 |
Myasthenic Syndrome, Congenital
(NGS) |
8630 |
85 |
2090100 |
Myelodysplastic syndrome (NGS) |
10430 |
86 |
2090101 |
Myopathy, Distal (NGS) |
10430 |
87 |
2090103 |
Myotonia (NGS) |
6830 |
88 |
2090104 |
Nephrocalcinosis (NGS) |
10430 |
89 |
2090105 |
Neurodegeneration with Brain Iron
Accumulation (NBIA) (NGS) |
8630 |
90 |
2090106 |
Neurofibromatosis (NF) (NGS) |
6830 |
91 |
2090107 |
Neuronal Migration Disorder (NGS) |
10430 |
92 |
2090108 |
NK/T-Cell Lymphoma (NGS) |
6830 |
93 |
2090109 |
Nystagmus (NGS) |
6830 |
94 |
2090110 |
Obesity (NGS) |
10430 |
95 |
2090112 |
Pancreas Carcinoma (NGS) |
8630 |
96 |
2090113 |
Pancreatitis, Chronic (NGS) |
6830 |
97 |
2090114 |
Parkinson Disease (NGS) |
13966 |
98 |
2090115 |
Pena-Shokeir Syndrome (NGS) |
8630 |
99 |
2090116 |
Pendred Syndrome (NGS) |
8630 |
100 |
2090117 |
Periodic Fever Syndromes/Autoinflammation
(NGS) |
10430 |
101 |
2090118 |
Peripheral T-Cell Lymphoma (NGS) |
6830 |
102 |
2090119 |
Perrault Syndrome (NGS) |
6830 |
103 |
2090120 |
Polymicrogyria (NGS) |
8630 |
104 |
2090121 |
Pontocerebellar Hypoplasia (NGS) |
6830 |
105 |
2090122 |
Porphyria (NGS) |
6830 |
106 |
2090123 |
Progeria Syndromes (NGS) |
8630 |
107 |
2090124 |
Progressive External Ophthalmoplegia
(PEO) (NGS) |
8630 |
108 |
2090125 |
Prostate Cancer (NGS) |
10430 |
109 |
2090126 |
Pulmonary Hypertension (NGS) |
6830 |
110 |
2090127 |
Pyruvate Dehydrogenase Deficiency
(NGS) |
6830 |
111 |
2090128 |
Rasopathies (NGS) |
8630 |
112 |
2090129 |
Refsum Syndrome (NGS) |
8630 |
113 |
2090131 |
Renal Carcinoma (NGS) |
8630 |
114 |
2090132 |
Retinitis Pigmentosa (NGS) |
10430 |
115 |
2090133 |
Retinoblastoma (NGS) |
6830 |
116 |
2090134 |
SANDD Syndrome (NGS) |
6830 |
117 |
2090135 |
Schizencephaly (NGS) |
6830 |
118 |
2090136 |
Short Stature (NGS) |
8630 |
119 |
2090137 |
Skeletal Dyplasia with Abnormal Bone
Density/Mineralisation (NGS) |
8630 |
120 |
2090138 |
Spastic Paraplegia (NGS) |
10430 |
121 |
2090139 |
Spinal Muscular Atrophy, Distal
(NGS) |
10430 |
122 |
2090140 |
Splenic Marginal Zone Lymphoma (NGS) |
6830 |
123 |
2090141 |
Spondylometaphyseal Dysplasia and
Spondyloepiphyseal Dysplasia (NGS) |
10430 |
124 |
2090142 |
Stargardt Disease (NGS) |
6830 |
125 |
2090143 |
Stickler Syndrome (NGS) |
6830 |
126 |
2090145 |
Thrombotic Microangiopathy (TMA)
(NGS) |
8630 |
127 |
2090146 |
Thrombotic Thrombocytopenic Purpura
(TTP) (NGS) |
8630 |
128 |
2090147 |
Treacher Collins Syndrome (NGS) |
6830 |
129 |
2090148 |
Walker-Warburg Syndrome (NGS) |
8630 |
130 |
2090149 |
Warburg-Micro Syndrome (NGS) |
10430 |
131 |
2090150 |
Xanthinuria (NGS) |
6830 |
132 |
2090151 |
Xeroderma Pigmentosum (NGS) |
6830 |
133 |
2090152 |
X-linked mental retardation (NGS) |
10430 |
134 |
2090154 |
Albinism, Oculocutaneous (MC1R) |
1655 |
135 |
2090155 |
Alpha-1-Antitrypsin Deficiency
(SERPINA1) |
980 |
136 |
2090156 |
Alpha-Thalassemia (HBA, HBA2,
sequencing + MLPA) |
2780 |
137 |
2090157 |
Pulmonary Alveolar Microlithiasis
(SLC34A2) |
3680 |
138 |
2090158 |
Amyloidosis, Hereditary,
Transthyretin-related (TTR, stage 1) |
980 |
139 |
2090159 |
Amyloidosis, Hereditary,
Transthyretin-related (TTR, stage 2) |
1295 |
140 |
2090160 |
Arthrogryposis (TNNI2) |
2105 |
141 |
2090161 |
Arts Syndrome (PRPS1) |
2330 |
142 |
2090162 |
Ataxia Teleangiectasia (ATM) |
6830 |
143 |
2090163 |
Ataxia Teleangiectasia (ATM, MLPA) |
1880 |
144 |
2090164 |
Beta-Propeller Protein-Associated Neurodegeneration
(WDR45) |
2555 |
145 |
2090166 |
Blepharophimosis (FOXL2) |
980 |
146 |
2090167 |
Hypertension and Brachydactyly
Syndrome (PDE3A) |
5399 |
147 |
2090169 |
Coenzyme Q10 Deficiency (NGS) |
8630 |
148 |
2090170 |
Cohesinopathies (e.g. Cornelia de
Lange Syndrome) (NGS) |
6830 |
149 |
2090171 |
Cowden Syndrome 3 (NGS) |
6830 |
150 |
2090172 |
CTNNB1-Associated Diseases (CTNNB1) |
3905 |
151 |
2090173 |
Donnai-Barrow Syndrome (LRP2) |
6830 |
152 |
2090174 |
Dravet Syndrome (GABRG2) |
3455 |
153 |
2090176 |
Ellis-Van-Creveld Syndrome (EVC,
EVC2, MLPA) |
1880 |
154 |
2090177 |
Encephalopathy Syndrome, Lethal
Neonatal Spasticity-Epileptic (BRAT1) |
5030 |
155 |
2090178 |
Epileptic Encephalopathy (WWOX) |
3005 |
156 |
2090180 |
Fleck Retina, Familial Benign
(PLA2G5) |
1565 |
157 |
2090181 |
Exudative Vitreoretinopathy (LRP5) |
6830 |
158 |
2090182 |
Exudative Vitreoretinopathy Type 1
(FZD4) |
1115 |
159 |
2090183 |
Familial Isolated Arrhythmogenic
Ventricular Dysplasia (PKP2) |
5317 |
160 |
2090184 |
X-Linked Intellectual Disability
(OPHN1) |
4580 |
161 |
2090185 |
Limb-Girdle Muscular Dystrophy Type
2D (SGCA) |
3157 |
162 |
2090186 |
Glioma (POT1) (NGS) |
4580 |
163 |
2090187 |
Hemolytic-Uremic Syndrome, Atypical
(AHUS3/CFI) |
3110 |
164 |
2090188 |
Hemolytic-Uremic Syndrome, Atypical
(AHUS5/C3) |
5930 |
165 |
2090189 |
Hemolytic-Uremic Syndrome, Atypical
(AHUS7/DGKE) |
3005 |
166 |
2090190 |
Hermansky-Pudlak syndrome 1 (HPS1) |
5030 |
167 |
2090191 |
Hermansky-Pudlak Syndrome 3 (HPS3) |
5030 |
168 |
2090192 |
Hermansky Pudlak Syndrome 5 (HPS5) |
5030 |
169 |
2090193 |
Hermansky-Pudlak Syndrome 6 (HPS6) |
2371 |
170 |
2090194 |
Hermansky-Pudlak Syndrome 8
(HPS8/BLOC1S3) |
980 |
171 |
2090195 |
HIV Infection,
Susceptibility/Resistance to (CCR5) |
980 |
172 |
2090196 |
Corneal Dystrophy (SLC4A11) |
5480 |
173 |
2090197 |
Hyper-IgE Syndrome-NGS (NGS) |
6830 |
174 |
2090198 |
Hyperlipoproteinemia (APOA5) (NGS) |
6830 |
175 |
2090199 |
Hypophosphatemia with Hypercalciuria
(SLC34A3) |
2555 |
176 |
2090200 |
Hypophosphatemia with
Nephrolithiasis or Osteoporosis (SLC34A1) |
4008 |
177 |
2090201 |
Hypophosphatemic Rickets, Autosomal
Dominant (FGF23, MLPA) |
1913 |
178 |
2090202 |
Imerslund-Grasbeck Syndrome (AMN) |
3095 |
179 |
2090203 |
Jalili Syndrome (cone-rod retinal
dystrophy and amelogenesis imperfecta) (CNNM4) |
3026 |
180 |
2090204 |
Jervell- and Lange-Nielsen Syndrome
(NGS) |
6830 |
181 |
2090205 |
Joubert Syndrome (POC1B) |
3905 |
182 |
2090206 |
Campomelic Dysplasia (SOX9, MLPA) |
1880 |
183 |
2090207 |
Cataract Syndrome (CRYAA) |
1880 |
184 |
2090208 |
Cataract 14, Multiple Types (GJA3) |
980 |
185 |
2090210 |
Lathosterolosis (SC5DL) |
3680 |
186 |
2090211 |
Legius syndrome (SPRED1) |
2465 |
187 |
2090213 |
Lesch-Nyhan syndrome (HPRT1, MLPA) |
2371 |
188 |
2090215 |
Lujan-Fryns Syndrome (MED12) (NGS) |
6830 |
189 |
2090216 |
Mayer-Rokitansky-Küster-Hauser
Syndrome (WNT4) |
2015 |
190 |
2090217 |
Megalencephaly-Capillary
Malformation-Polymicrogyria Syndrome, Somatic (PIK3CA ) |
5930 |
191 |
2090218 |
Microcephaly (ASPM) |
6830 |
192 |
2090219 |
Microcephaly (KIF11) |
4130 |
193 |
2090220 |
Microcephaly (PCNT) |
10430 |
194 |
2090221 |
Microcephaly (RBBP8) |
5930 |
195 |
2090222 |
Microcephaly (SLC25A19) |
2555 |
196 |
2090223 |
Mitochondrial DNA Depletion Syndrome
(DGUOK) |
2830 |
197 |
2090224 |
Wilson Disease (ATP7B, Stage 3,
MLPA) |
1880 |
198 |
2090226 |
Myotonia Congenita Type
Becker/Thomsen (CLCN1, MLPA) |
2155 |
199 |
2090227 |
Nephronophthisis (NPHP4) |
5930 |
200 |
2090228 |
Nephronophthisis-like Nephropathy
(NPHPL1/XPNPEP3) |
3353 |
201 |
2090230 |
Nephrotic Syndrome (WDR73) |
2465 |
202 |
2090231 |
Retinal Dystrophy (RGS9BP) |
980 |
203 |
2090232 |
Hereditary Sensory and Autonomic
Neuropathy Type 5 (NGF) |
1295 |
204 |
2090233 |
Noonan-like Syndrome with Loose
Anagen Hair (SHOC2) |
3095 |
205 |
2090234 |
Osteopathia Striata, Cranial
Sclerosis (AMER1/WTX) |
2465 |
206 |
2090235 |
Paralysis, Thyrotoxic Periodic
(KCNJ18) |
1295 |
207 |
2090236 |
Perrault Syndrome (CLPP) |
1880 |
208 |
2090237 |
Perrault Syndrome (LARS2) |
4662 |
209 |
2090238 |
Polycystic Liver Disease (GANAB) |
6155 |
210 |
2090240 |
Retinol Dystrophy, Iris coloboma,
and Comedogenic Acne Syndrome (RBP4) |
1655 |
211 |
2090241 |
Retinitis Pigmentosa (IMPG2) |
6830 |
212 |
2090242 |
Retinitis Pigmentosa (LRAT) |
1115 |
213 |
2090243 |
Retinitis Pigmentosa (NR2E3) |
3095 |
214 |
2090244 |
Rett-like syndrome (NTNG1, MLPA) |
1880 |
215 |
2090245 |
Rett-like syndrome (NTNG1, Seq.) |
2195 |
216 |
2090246 |
Robinow Syndrome (WNT5A) |
4355 |
217 |
2090247 |
Deafness (GPSM2) |
4580 |
218 |
2090248 |
Very Long Chain Acyl-CoA
Dehydrogenase Deficiency (ACADVL) |
6380 |
219 |
2090249 |
Simpson-Golabi-Behmel Syndrome
(GPC3) (Testicular Feminization Syndrome) |
3353 |
220 |
2090251 |
TARP Syndrome (RBM10) |
5930 |
221 |
2090254 |
Hyperphosphatemic Tumoral
Calcinosis, Familial (GALNT3) |
5534 |
222 |
2090255 |
Vasculopathy, ADA2 Deficiency
(CECR1) |
3005 |
223 |
2090256 |
Wolman Disease (LIPA) |
3005 |
224 |
2090257 |
Cone-Rod Dystrophy (CTNNA1) |
4355 |
225 |
2090258 |
Congenital Adrenal Hyperplasia (NGS) |
8630 |
226 |
2090259 |
Lysosomal Perioxisomal Disorders NGS |
10430 |
227 |
2090260 |
CYP21A2 Deletion & Duplication
(MLPA) |
1880 |
228 |
2090261 |
Microarray CGH 180 K Amniotic
Fluid/CVS |
6750 |
229 |
2090262 |
PTEN Gene Amniotic fluid/CVS |
2925 |
230 |
2090263 |
Skeletal Dysplasia and Pena Shokeir
Syndrome |
8630 |
231 |
2090264 |
Methylation Test Russel Siver
Syndrome |
1880 |
232 |
2090265 |
Ichthyoses and Related Disorder
panels |
10430 |
233 |
2090266 |
Heteroxy and Situs Inversion Panel |
10430 |
234 |
2090267 |
Multi Gene Panel- Mitochondrial |
10430 |
235 |
2090268 |
Sister Chromatid Exchange for Bloom
Syndrome. |
1871 |
236 |
2090269 |
Breast Cancer Mutigene Panel-NGS |
8630 |
237 |
2090270 |
Medium Chain Acyl CoA Deficiecy |
3905 |
238 |
2090271 |
Gastrointestinal Atresia Panel |
6626 |
239 |
2090272 |
KGB Syndrome |
3680 |
240 |
2090273 |
Neurofascins Abs.(140 & 155) |
1954 |
241 |
2090274 |
Contactin- 1 (CASPR1) |
1138 |
242 |
2090275 |
Amlodipine |
418 |
243 |
2090276 |
Beta HCG(CSF) |
454 |
244 |
2090277 |
Alpha Feto protein (AFP) (CSF) |
205 |
245 |
2090278 |
HIV Viral load(CSF) |
945 |
246 |
2090279 |
5 Methyl Tetra Hydro folate(CSF) |
1221 |
247 |
2090280 |
Pregnanacy Associated Plasma
Protein(PAPP-A) |
305 |
248 |
2090281 |
Rituximab Neutralizing Abs |
2905 |
249 |
2090282 |
Omega 6 Fatty Acids Screen |
306 |
250 |
2090283 |
Chlamydia Trachomatis IgA &
IgG ABS |
251 |
251 |
2090284 |
Chlamydia Pneumonia IgM & IgG
ABS |
251 |
252 |
2090285 |
Zika Virus IgG/IgM ABS |
305 |
253 |
2090286 |
Entero Virus RNA PCR |
741 |
254 |
2090287 |
Legionella Culture Specimen |
162 |
255 |
2090288 |
Porphyrin |
251 |
256 |
2090289 |
Porphobilinogen |
251 |
257 |
2090290 |
Pseudomonas Aeruginosa Abs. |
445 |
258 |
2090291 |
Oncotype DX (21 GENES) |
22080 |
259 |
2090292 |
Iodine Urine |
113 |
260 |
2090293 |
Cytomegalovirus PCR CSF |
233 |
261 |
2090294 |
Chickengunya Virus RNA PCR |
395 |
262 |
2090295 |
Dihydropteridine Reductase
(DHPR) Activity |
305 |
263 |
2090296 |
Fibroblast Growth Factor 23 Level |
180 |